Skip to content
Topics/Environmental Injuries

Mushroom Poisoning

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
10 questions available
Easy · 3
Medium · 6
Hard · 1

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Pro
54M with intractable seizures after foraging

A 54-year-old male presents with severe nausea, vomiting, and new-onset refractory seizures hours after consuming wild 'morels'.

hard
~15 min
Pro
45F with delayed-onset vomiting and diarrhea

A 45-year-old female presents with profuse cholera-like diarrhea and vomiting starting 12 hours after eating a wild mushroom stew.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

  • Gyromitrin Toxicity: Certain mushrooms (often mistaken for edible morels) contain gyromitrin, an isoniazid-like toxin. This toxin directly interferes with GABA synthesis, leading to refractory, intractable seizures.
  • Psilocybin (Hallucinogenic): Psilocybe species contain psilocybin, which is rapidly dephosphorylated by alkaline phosphatase in the body into the highly psychoactive chemical psilocin. Psilocin directly acts on central nervous system serotonergic neurons, producing hallucinogenic effects mimicking lysergic acid diethylamide (LSD).
  • Muscarinic Toxicity: Ingestions of Inocybe and Clitocybe species trigger a direct parasympathetic/cholinergic syndrome (muscarinic syndrome) typically occurring less than 30 minutes post-ingestion.
  • Cyclopeptide (Amanita) Toxicity: Though initial symptoms may be delayed, these toxins cause severe, progressive hepatic necrosis that frequently necessitates liver transplantation.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

  • Initial Stabilization: The mainstay of general mushroom poisoning is symptom-based supportive care and fluid resuscitation.
  • Decontamination: Routine administration of activated charcoal has no proven outcome benefit for all mushroom ingestions. It is only recommended if it can be administered within 1 hour of the ingestion. However, for suspected Amanita poisoning, multiple-dose activated charcoal is specifically indicated.
  • Gyromitrin-Induced Seizures: Traditional seizure medications (like benzodiazepines) will likely fail. You must administer intravenous Pyridoxine to halt intractable gyromitrin-induced seizures.
  • Targeted Therapy for Amanita: For suspected Amanita ingestions, rapidly initiate specific medical therapies:
  • N-acetylcysteine (150 mg/kg loading dose).
  • Penicillin G (300,000–1,000,000 units/kg/day).
  • Silymarin (20–40 mg/kg/day), where available.
  • Cimetidine (4–10 grams/day).

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

  • Critical "Can't-Miss" Mimics:
  • Standard gastroenteritis or food poisoning.
  • Pancreatitis or hepatitis.
  • Acute renal failure.
  • Anticholinergic or cholinergic toxidromes from other sources.
  • Disulfiram toxicity.
  • Prioritized Diagnostic Workup:
  • Toxin Identification (Gold Standard): Do not attempt to identify the mushroom yourself. Coordinate immediately with the poison control center and local mycologists. Sending digital smartphone photographs of the mushroom for real-time identification is highly accurate and strongly recommended.
  • Baseline Labs: Order a CBC, urinalysis, and basic metabolic profile, paying specific attention to renal function and markers of severe dehydration.
  • Hepatic Panel: Liver enzymes and comprehensive liver function tests are strictly mandated if cyclopeptide (Amanita) or gyromitrin poisoning is suspected.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

  • Visual Mushroom Identification (The Specimen):
  • Hallucinogenic Warning: Psilocybe species are typically small brown or gold mushrooms found on dung. A classic visual hallmark is that they turn a greenish-blue when bruised or cut.
  • The Morel Mimic: Gyromitrin-containing mushrooms clinically resemble edible morels, tricking amateur foragers.
  • Clinical Visuals: Assess the patient for profound cholinergic toxidrome signs (e.g., profound diaphoresis, emesis, miosis) characteristic of Inocybe or Clitocybe.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

  • The Timing Rule (Risk Stratification):
  • Early Onset (< 2 hours): Patients presenting with severe nausea, vomiting, and diffuse abdominal pain roughly 1 hour after ingestion generally have a benign clinical course. These can be safely managed with symptomatic treatment and observation.
  • Delayed Onset (> 6 hours): A delayed onset of symptoms is a massive red flag for lethal cyclopeptide toxicity, mandating aggressive workup and interventions.
  • Disposition Criteria: Patients with early-onset symptoms can be safely discharged from the ED once vomiting has subsided and they are tolerating oral fluids. Provide strict return precautions for any urinary changes or lumbar/flank pain. Patients with suspected Amanita exposure require transfer to a center with an active liver transplant program.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

  • Pitfall (Seizure Mismanagement): Attempting to treat gyromitrin-induced seizures exclusively with standard medications like phenobarbital, phenytoin, or propofol. These seizures are driven by an isoniazid-like toxin and will be intractable until the specific antidote is given.
  • Pitfall (Premature Reassurance): Discharging a patient who has a delayed onset of gastrointestinal symptoms. Delayed onset portends lethal hepatic or renal failure.
  • Pitfall (Assuming Pure Exposure): Failing to recognize that "street-bought" nontoxic mushrooms sold as hallucinogens are frequently laced with phencyclidine (PCP) or LSD, which will alter the patient's toxidrome.
  • CRITICAL ACTION: You must immediately administer Pyridoxine for refractory seizures in a patient who recently consumed wild "morel" mushrooms.
  • CRITICAL ACTION: You must contact a poison control center and a mycologist for formal identification, especially if the patient presents with delayed-onset symptoms.

7. MCQ MASTERCLASS (Written Exam Tips)

  • Buzzwords: "Isoniazid-like toxin", "seizures after eating morels", or "intractable seizures unresponsive to benzodiazepines" $\rightarrow$ Gyromitrin poisoning. The exact answer is to administer Pyridoxine.
  • Buzzwords: "Small brown mushroom", "turns greenish-blue when bruised", "LSD-like effects" $\rightarrow$ Psilocybin (Psilocybe genus).
  • Common Distractor: A question stem will describe a patient with severe vomiting 1 hour after eating wild mushrooms and ask for the "most concerning" finding or "best next step." Distractors will include "N-acetylcysteine" or "prepare for liver transplant." Because the symptoms are early-onset (1 hour), the correct answer is usually "symptomatic treatment" or "reassurance," as early symptoms typically indicate a benign course.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

  • High-Stress Articulation: "Given the patient's ingestion of an unknown wild mushroom, my immediate priority is to establish the timeline of symptom onset. Because the symptoms started several hours after ingestion, I am highly concerned for a delayed-toxin ingestion such as Amanita."
  • Diagnostic Phrasing: "Nurse, please obtain a basic metabolic panel, hepatic function panel, and coagulation studies. I will also contact the poison control center immediately and send digital photographs of the remaining mushroom to the on-call mycologist for definitive identification.".
  • Management Phrasing: "The patient's seizures are refractory to initial benzodiazepines. Given the history of foraging 'morel' mushrooms, I suspect gyromitrin toxicity. I am ordering intravenous pyridoxine immediately as the definitive antidote.".